Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-08-08 Sale | 2023-08-10 4:11 pm | G1 Therapeutics Inc. | GTHX | Velleca Mark A. Director | 60,000 | $1.9996 | $119,974 | 358,286 (Direct) | View |
| 2022-10-18 Sale | 2022-10-20 4:05 pm | G1 Therapeutics Inc. | GTHX | Velleca Mark A. Director | 15,000 | $11.7 | $175,490 | 173,286 (Direct) | View |
| 2022-09-20 Sale | 2022-09-22 4:40 pm | G1 Therapeutics Inc. | GTHX | Velleca Mark A. Director | 20,000 | $13.5 | $270,044 | 188,286 (Direct) | View |
| 2022-08-16 Sale | 2022-08-18 4:06 pm | G1 Therapeutics Inc. | GTHX | Velleca Mark A. Director | 80,000 | $12.64 | $1,010,904 | 208,286 (Direct) | View |
| 2021-07-13 Sale | 2021-07-15 4:01 pm | G1 Therapeutics Inc. | GTHX | Velleca Mark A. Director | 30,000 | $19.01 | $570,258 | 772,858 (Direct) | View |
| 2021-06-15 Sale | 2021-06-17 4:05 pm | G1 Therapeutics Inc. | GTHX | Velleca Mark A. Director | 30,000 | $21.97 | $659,021 | 862,858 (Direct) | View |
| 2021-05-11 Sale | 2021-05-13 4:43 pm | G1 Therapeutics Inc. | GTHX | Velleca Mark A. Director | 30,000 | $19.9 | $597,101 | 992,858 (Direct) | View |
| 2021-04-13 Sale | 2021-04-15 5:53 pm | G1 Therapeutics Inc. | GTHX | Velleca Mark A. Director | 30,000 | $24.46 | $733,768 | 1,082,858 (Direct) | View |
| 2021-02-16 Sale | 2021-02-18 5:49 pm | G1 Therapeutics Inc. | GTHX | Velleca Mark A. Director | 31,040 | $29.81 | $925,238 | 156,179 (Direct) | View |
| 2021-01-19 Sale | 2021-01-21 5:31 pm | G1 Therapeutics Inc. | GTHX | Velleca Mark A. Director | 30,000 | $21.01 | $630,288 | 616,585 (Direct) | View |
| 2020-12-15 Sale | 2020-12-17 6:01 pm | G1 Therapeutics Inc. | GTHX | Velleca Mark A. President and CEO | 30,000 | $19.53 | $585,986 | 335,299 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-02-14 Option Award | 2024-02-15 5:35 pm | N/A 2034-02-13 | Black Diamond Therapeutics Inc. | BDTX | Velleca Mark A. PRESIDENT & CEO | 537,000 | $0 | 537,000 (Direct) | View |
| 2023-09-15 Option Award | 2023-09-18 5:26 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Velleca Mark A. PRESIDENT & CEO | 5,208 | $3.6 | 1,046,522 (Direct) | View |
| 2023-09-17 Option Award | 2023-09-18 5:26 pm | N/A 2033-09-16 | Black Diamond Therapeutics Inc. | BDTX | Velleca Mark A. PRESIDENT & CEO | 1,000,000 | $0 | 1,046,522 (Direct) | View |
| 2023-08-08 Exercise | 2023-08-10 4:11 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | Velleca Mark A. Director | 57,286 | $0.39 | 358,286 (Direct) | View |
| 2023-08-08 Exercise | 2023-08-10 4:11 pm | N/A 2024-05-09 | G1 Therapeutics Inc. | GTHX | Velleca Mark A. Director | 60,000 | $0 | 358,286 (Direct) | View |
| 2023-08-08 Exercise | 2023-08-10 4:11 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | Velleca Mark A. Director | 2,714 | $0.3 | 358,286 (Direct) | View |
| 2023-06-16 Option Award | 2023-06-16 5:41 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Velleca Mark A. Director | 8,929 | $2.1 | 41,314 (Direct) | View |
| 2023-05-16 Option Award | 2023-05-17 9:09 pm | N/A 2033-05-15 | Black Diamond Therapeutics Inc. | BDTX | Velleca Mark A. Director | 16,500 | $0 | 16,500 (Direct) | View |
| 2023-03-16 Option Award | 2023-03-20 4:33 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Velleca Mark A. Director | 11,228 | $1.67 | 32,385 (Direct) | View |
| 2022-12-16 Option Award | 2022-12-19 9:16 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Velleca Mark A. Director | 8,424 | $1.5 | 21,157 (Direct) | View |
| 2022-10-18 Exercise | 2022-10-20 4:05 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | Velleca Mark A. Director | 15,000 | $0.39 | 173,286 (Direct) | View |
| 2022-10-18 Exercise | 2022-10-20 4:05 pm | N/A 2024-05-09 | G1 Therapeutics Inc. | GTHX | Velleca Mark A. Director | 15,000 | $0 | 173,286 (Direct) | View |
| 2022-09-20 Exercise | 2022-09-22 4:40 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | Velleca Mark A. Director | 20,000 | $0.39 | 188,286 (Direct) | View |
| 2022-09-20 Exercise | 2022-09-22 4:40 pm | N/A 2024-05-09 | G1 Therapeutics Inc. | GTHX | Velleca Mark A. Director | 20,000 | $0 | 188,286 (Direct) | View |
| 2022-09-16 Option Award | 2022-09-19 5:09 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Velleca Mark A. Director | 4,294 | $2.62 | 12,733 (Direct) | View |
| 2022-08-16 Exercise | 2022-08-18 4:06 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | Velleca Mark A. Director | 80,000 | $0.39 | 208,286 (Direct) | View |
| 2022-08-16 Exercise | 2022-08-18 4:06 pm | N/A 2024-05-09 | G1 Therapeutics Inc. | GTHX | Velleca Mark A. Director | 80,000 | $0 | 208,286 (Direct) | View |
| 2022-06-17 Option Award | 2022-06-17 4:27 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Velleca Mark A. Director | 5,542 | $2.03 | 8,439 (Direct) | View |
| 2022-06-10 Option Award | 2022-06-13 7:08 pm | N/A 2032-06-09 | Black Diamond Therapeutics Inc. | BDTX | Velleca Mark A. Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2022-03-18 Option Award | 2022-03-18 4:05 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Velleca Mark A. Director | 2,897 | $3.02 | 2,897 (Direct) | View |
| 2022-02-07 Exercise | 2022-02-08 4:05 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | Velleca Mark A. Director | 15,000 | $0.39 | 288,286 (Direct) | View |
| 2022-02-07 Exercise | 2022-02-08 4:05 pm | N/A 2024-05-09 | G1 Therapeutics Inc. | GTHX | Velleca Mark A. Director | 15,000 | $0 | 288,286 (Direct) | View |
| 2021-11-09 Exercise | 2021-11-10 4:05 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | Velleca Mark A. Director | 40,000 | $0.39 | 288,286 (Direct) | View |
| 2021-11-09 Exercise | 2021-11-10 4:05 pm | N/A 2024-05-09 | G1 Therapeutics Inc. | GTHX | Velleca Mark A. Director | 40,000 | $0 | 288,286 (Direct) | View |
| 2021-08-09 Option Award | 2021-08-11 4:58 pm | N/A 2031-08-08 | Black Diamond Therapeutics Inc. | BDTX | Velleca Mark A. Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2021-07-13 Exercise | 2021-07-15 4:01 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | Velleca Mark A. Director | 30,000 | $0.39 | 772,858 (Direct) | View |
| 2021-07-13 Exercise | 2021-07-15 4:01 pm | N/A 2024-05-09 | G1 Therapeutics Inc. | GTHX | Velleca Mark A. Director | 30,000 | $0 | 772,858 (Direct) | View |
| 2021-06-15 Exercise | 2021-06-17 4:05 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | Velleca Mark A. Director | 30,000 | $0.39 | 862,858 (Direct) | View |
| 2021-06-15 Exercise | 2021-06-17 4:05 pm | N/A 2024-05-09 | G1 Therapeutics Inc. | GTHX | Velleca Mark A. Director | 30,000 | $0 | 862,858 (Direct) | View |
| 2021-05-25 Exercise | 2021-05-25 6:29 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | Velleca Mark A. Director | 20,000 | $0.39 | 348,286 (Direct) | View |
| 2021-05-25 Exercise | 2021-05-25 6:29 pm | N/A 2024-05-09 | G1 Therapeutics Inc. | GTHX | Velleca Mark A. Director | 20,000 | $0 | 348,286 (Direct) | View |
| 2021-05-11 Exercise | 2021-05-13 4:43 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | Velleca Mark A. Director | 30,000 | $0.39 | 992,858 (Direct) | View |
| 2021-05-11 Exercise | 2021-05-13 4:43 pm | N/A 2024-05-09 | G1 Therapeutics Inc. | GTHX | Velleca Mark A. Director | 30,000 | $0 | 992,858 (Direct) | View |
| 2021-04-13 Exercise | 2021-04-15 5:53 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | Velleca Mark A. Director | 30,000 | $0.39 | 1,082,858 (Direct) | View |
| 2021-04-13 Exercise | 2021-04-15 5:53 pm | N/A 2024-05-09 | G1 Therapeutics Inc. | GTHX | Velleca Mark A. Director | 30,000 | $0 | 1,082,858 (Direct) | View |
| 2021-02-16 Exercise | 2021-02-18 5:49 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | Velleca Mark A. Director | 31,040 | $3.72 | 156,179 (Direct) | View |
| 2021-02-16 Exercise | 2021-02-18 5:49 pm | N/A 2025-12-21 | G1 Therapeutics Inc. | GTHX | Velleca Mark A. Director | 31,040 | $0 | 156,179 (Direct) | View |
| 2021-01-19 Exercise | 2021-01-21 5:31 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | Velleca Mark A. Director | 30,000 | $3.72 | 616,585 (Direct) | View |
| 2021-01-20 Exercise | 2021-01-21 5:31 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | Velleca Mark A. Director | 4,000 | $0.39 | 616,585 (Direct) | View |
| 2021-01-19 Exercise | 2021-01-21 5:31 pm | N/A 2025-12-21 | G1 Therapeutics Inc. | GTHX | Velleca Mark A. Director | 34,000 | $0 | 616,585 (Direct) | View |
| 2020-12-15 Exercise | 2020-12-17 6:01 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | Velleca Mark A. President and CEO | 30,000 | $3.72 | 335,299 (Direct) | View |
| 2020-12-15 Exercise | 2020-12-17 6:01 pm | N/A 2025-12-21 | G1 Therapeutics Inc. | GTHX | Velleca Mark A. President and CEO | 30,000 | $0 | 335,299 (Direct) | View |
| 2020-03-13 Exercise | 2020-03-16 07:00 am | N/A N/A | G1 Therapeutics Inc. | GTHX | Velleca Mark A. President and CEO | 3,000 | $0.39 | 408,286 (Direct) | View |
| 2020-03-13 Exercise | 2020-03-16 07:00 am | N/A 2024-05-09 | G1 Therapeutics Inc. | GTHX | Velleca Mark A. President and CEO | 3,000 | $0 | 408,286 (Direct) | View |
| 2020-02-06 Option Award | 2020-02-07 4:14 pm | N/A 2030-02-06 | G1 Therapeutics Inc. | GTHX | Velleca Mark A. President and CEO | 220,000 | $0 | 220,000 (Direct) | View |
| 2020-01-23 Exercise | 2020-01-24 4:59 pm | N/A N/A | G1 Therapeutics Inc. | GTHX | Velleca Mark A. President and CEO | 6,000 | $0.39 | 408,286 (Direct) | View |
| 2020-01-23 Exercise | 2020-01-24 4:59 pm | N/A 2024-05-09 | G1 Therapeutics Inc. | GTHX | Velleca Mark A. President and CEO | 6,000 | $0 | 408,286 (Direct) | View |